2500720UGMouse CCL5 RANTES Recombinant Protei and 3 more items

Life Technologies Corporation has been awarded a contract by Virginia Commonwealth University under award number A236_P0343090, effective June 29, 2026. The contract total value is $882 and encompasses the supply of recombinant protein products delivered to VCU Procurement in Virginia. The four line items consist of murine and human cytokine proteins: Mouse CCL5 (RANTES), Mouse CXCL1 (GRO alpha), Mouse CCL3 (MIP1 alpha), and Human ENA78 (CXCL5), each priced at $220.50 per unit with a quantity of one unit each.

These recombinant proteins are research-grade biological reagents commonly utilized in immunology and cell biology applications. The procurement represents a straightforward materials supply arrangement for laboratory research purposes at Virginia Commonwealth University. Each protein product is delivered as a single unit, reflecting the specialized nature of these high-value research materials required for ongoing investigative work at the institution.